Visit https://www.peervoice.com/TTZ860 to view the entire programme with slides. After completing “Picturing a Different Future in CKD: A Call to Action”, participants will be able to: Explain the rationale for SGLT2 inhibitors in the management of CKD, in patient with and without type 2 diabetes (T2DM); Describe the emerging standards of care for management of patients with CKD, with and without T2DM; Integrate the most current clinical data and guidelines for management of CKD into practice.